Pfizer beats Q1 profit estimates on demand for newly acquired drugs, COVID products Ruchika Sharma5 May 2023 7:00 AMThe company said it expects significantly lower sales contributions from COVID products in the second quarter from the first quarter.
Pfizer plan to sell its Haleon stake is not surprise: Consumer health company Finance chief Ruchika Sharma4 May 2023 8:00 AMHestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained...
Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer Ruchika Sharma2 May 2023 7:00 AMXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report Ruchika Sharma1 May 2023 8:45 AMBengaluru: Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay...
Pfizer gets USFDA approval for 20-valent Pneumococcal Conjugate Vaccine PREVNAR 20 for infants, children Ruchika Sharma28 April 2023 6:13 AMPREVNAR 20 builds on Pfizer's approved PREVNAR 13 vaccine, and includes seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) shown to be...
USFDA authorizes second Omicron-updated COVID booster for older adults Ruchika Sharma20 April 2023 11:00 AMUS: The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those...
Pfizer signs strategic cooperation pact with Sinopharm Ruchika Sharma16 April 2023 3:30 AMUnited States: Pfizer said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group, and plans to seek approval to...
Pfizer, Biogen among hundreds of US drugmakers calling for abortion pill Mifepristone ruling reversal Ruchika Sharma11 April 2023 6:45 AMThe FDA approved mifepristone, part of a two-drug regimen that accounts for more than half of US abortions, more than 20 years ago and has determined...
Pfizer RSV vaccine 82 percent effective in severe infection in infants: Data Ruchika Sharma7 April 2023 7:00 AMFDA approval could make Pfizer's shot the first maternal vaccine available to prevent the disease in infants.
Pfizer, BioNTech dragged to Court over COVID vaccine patent infringement once again Ruchika Sharma6 April 2023 8:00 AMUS: Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming...
USFDA accepts Pfizer supplemental new drug applications for BRAFTOVI plus MEKTOVI Ruchika Sharma5 April 2023 6:30 AMNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 10:30 AMPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
